Unveiling the Significance of Peroxiredoxin 6 in Central Nervous System Disorders.
Prdx6
central nervous system
glutathione peroxidase
neurodegeneration
neuroinflammation
phospholipase A2
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
10 Apr 2024
10 Apr 2024
Historique:
received:
01
03
2024
revised:
01
04
2024
accepted:
09
04
2024
medline:
27
4
2024
pubmed:
27
4
2024
entrez:
27
4
2024
Statut:
epublish
Résumé
Peroxiredoxin 6 (Prdx6), a unique 1-Cys member of the peroxiredoxin family, exhibits peroxidase activity, phospholipase activity, and lysophosphatidylcholine acyltransferase (LPCAT) activity. Prdx6 has been known to be an important enzyme for the maintenance of lipid peroxidation repair, cellular metabolism, inflammatory signaling, and antioxidant damage. Growing research has demonstrated that the altered activity of this enzyme is linked with various pathological processes including central nervous system (CNS) disorders. This review discusses the distinctive structure, enzyme activity, and function of Prdx6 in different CNS disorders, as well as emphasizing the significance of Prdx6 in neurological disorders.
Identifiants
pubmed: 38671897
pii: antiox13040449
doi: 10.3390/antiox13040449
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Lijie Feng;Min Xue
ID : 81973337; 2023zhyx-C01; gxyqZD2020010; 2020xkjT002; 2023xkj001